STAT

Illness in doctors: a source of expertise, not a sign of weakness

Serious illness among medical students, trainees, and physicians should be seen as valuable life experiences, not weaknesses.
Source: GUILLAUME SOUVANT/AFP/Getty Images

I’ve been a medical student for the past three years and a cancer patient for nearly a decade. It’s harder than you think to be both at the same time.

As a student, I hear classmates boast about how many days it’s been since they last slept and how much junk food they eat to stay nourished. I’m expected to put in long hours, and show I’m keen by staying late even after my shift in the hospital has ended. After enough displays of conspicuous self-neglect, I’ll have earned my stripes. As a patient, though, I’m supposed to prioritize my health and pay attention to getting enough sleep, eating healthy food, and exercising. I’m responsible for doing my best

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Lilly’s Zepbound For Sleep Apnea, The FDA Budget, And More
Eli Lilly reported positive results for Zepbound in obstructive sleep apnea, giving the medication a new edge in the highly competitive obesity market.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About An Amgen Obesity Drug, A Senate Bill On Shortages, And More
Amgen will no longer develop an early-stage obesity pill, and will instead focus on a more advanced injectable candidate to compete with Wegovy and Zepbound.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Senate Probe Into Novo Pricing, A New UTI Antibiotic, And More
The U.S. Senate health committee is investigating the prices Novo Nordisk charges for its blockbuster medications Ozempic and Wegovy.

Related Books & Audiobooks